The epidemiology of amyloidosis in Australia
Amyloid
.
2019;26(sup1):132-133.
doi: 10.1080/13506129.2019.1582481.
Authors
Brendan Wisniowski
1
,
Donald McLeod
2
,
Rebecca Adams
3
4
5
,
Yasmin Harvey
6
,
Jane Armes
1
,
David Papadimos
6
,
Ian Brown
7
,
Lloyd McGuire
8
,
Peter Mollee
5
9
Affiliations
1
a Mater Health Services , Brisbane , Australia.
2
b QIMR Berghofer Medical Research Institute , Brisbane , Australia.
3
c QML Pathology , Brisbane , Australia.
4
d Pathology Queensland , Brisbane , Australia.
5
e University of Queensland , Brisbane , Australia.
6
f Sullivan Nicolaides Pathology , Brisbane , Australia.
7
g Envoi Pathology , Brisbane , Australia.
8
h Helix Pathology , Brisbane , Australia.
9
i Amyloidosis Centre, Princess Alexandra Hospital , Brisbane , Australia.
PMID:
31343339
DOI:
10.1080/13506129.2019.1582481
No abstract available
MeSH terms
Adult
Aged
Amyloidosis / diagnosis
Amyloidosis / mortality*
Amyloidosis / therapy
Disease-Free Survival
Female
Humans
Incidence
Male
Middle Aged
Queensland / epidemiology
Survival Rate